McPhillamys spend for FY21 is a minimum of A$15m. Regis will assess additional early long lead items and in the case of early approval of the Company’s Development Application by the Independent Planning Commission, the expenditure on McPhillamys for FY21 could be approximately A$60m. (Source: AGM Presenation 2020).
Any thoughts on what is meant with "early approval" ?
- Forums
- ASX - By Stock
- RRL
- Ann: Resources and Reserves Statement and Organic Growth Update
RRL
regis resources limited
Add to My Watchlist
2.23%
!
$4.39

Ann: Resources and Reserves Statement and Organic Growth Update, page-6
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$4.39 |
Change
-0.100(2.23%) |
Mkt cap ! $3.316B |
Open | High | Low | Value | Volume |
$4.47 | $4.53 | $4.37 | $16.81M | 3.793M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 51252 | $4.36 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.39 | 7201 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 4000 | 4.350 |
4 | 7325 | 4.300 |
1 | 1174 | 4.270 |
2 | 1435 | 4.250 |
1 | 2700 | 4.240 |
Price($) | Vol. | No. |
---|---|---|
4.420 | 5266 | 1 |
4.550 | 1000 | 1 |
4.570 | 222 | 1 |
4.580 | 6000 | 1 |
4.610 | 180 | 1 |
Last trade - 16.17pm 27/06/2025 (20 minute delay) ? |
Featured News
RRL (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online